Preventing pathological regression of blood vessels

Journal of Clinical Investigation

Volumn 112, Issue 1, 2003, Pages 27-29

  Keshet, Eli ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLACENTAL GROWTH FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; OXYGEN; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; SIGNAL PEPTIDE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

BLOOD VESSEL; HUMAN; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; REVIEW; VASCULAR DISEASE; ANIMAL; MOUSE; NEWBORN; NOTE; PATHOLOGY; PHYSIOLOGY; RETINA;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; OXYGEN; PREGNANCY PROTEINS; RETINA; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0041803035     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319093     Document Type: Review

References (16)

1. Alon, T., et al. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels: implications for retinopathy of prematurity. Nat. Med. 1:1024-1028.
2. Shih, S.-C., Ju, M.-H., Liu, N., and Smith, L.H.H. 2003. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J. Clin. Invest. 112:50-57. doi:10.1172/JCI200317808.
3. Persico, M.G., Vincenti, G., and DiPalma, T. 1999. Structure, expression and receptor-binding properties of placenta growth factor (PIGF). Curr. Top. Microbiol. Immunol. 237:31-40.
4. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 95:9349-9354.
5. Carmeliet, P., et al. 2001. Synergism between vascular endothelial growth factor and placenta growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7:575-583.
6. Luttun, A., et al. 2002. Revascularization of ischemic tissues by PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-flt1. Nat. Med. 8:831-840.
7. Eriksson, A., et al. 2002. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PIGF-1/VEGF heterodimers. Cancer Cell. 1:99-108.
8. Maynard, S.E., et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothilial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:649-658. doi:10.1172/JCI200317189.
9. Upalakalin, J.N., Hemo, I., Dehio, C., Kesher, E., and Benjamin, L.E. 2002. Survival mechanisms during vascular remodeling. Cold Spring Harbor Symp. Quant. Biol. 67:181-187.
10. Adini, A., Kornaga, T., Firoozbakhr, F., and Benjamin, L.E. 2002. Placental growth factor is a survival factor for rumor endothelial cells and macrophages. Cancer Res. 62:2749-2752.
11. Desai, J., Holt-Shore, V., Torry, R.J., Caudle, M.R., and Torry, D.S. 1999. Signal transduction and biological function of olacenta growth factor in primary human trophoblast. Biol. Reprod. 60:887-892.
12. Gratton, J.P., et al. 2001. Akt down-regulation of p38 signaling provides a novel mechanism for vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276:30359-30365.
13. Shiojima, I., and Walsh, K. 2002. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90:1243-1250.
14. Gerber, H.P., Dixit, V., and Ferrara, N. 1998. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273:13313-13316.
15. O'Connor, D.S., et al. 2000. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156:393-398.
16. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103:159-165.